BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 22234939)

  • 1. The PPARδ ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ.
    Park JH; Lee KS; Lim HJ; Kim H; Kwak HJ; Park HY
    J Cell Biochem; 2012 Jun; 113(6):1947-54. PubMed ID: 22234939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.
    Piqueras L; Reynolds AR; Hodivala-Dilke KM; Alfranca A; Redondo JM; Hatae T; Tanabe T; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):63-9. PubMed ID: 17068288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
    J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalein potently suppresses angiogenesis induced by vascular endothelial growth factor through the p53/Rb signaling pathway leading to G1/S cell cycle arrest.
    Ling Y; Chen Y; Chen P; Hui H; Song X; Lu Z; Li C; Lu N; Guo Q
    Exp Biol Med (Maywood); 2011 Jul; 236(7):851-8. PubMed ID: 21659383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
    Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways.
    Kim CK; Choi YK; Lee H; Ha KS; Won MH; Kwon YG; Kim YM
    Mol Pharmacol; 2010 Jul; 78(1):142-50. PubMed ID: 20406854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand activation of peroxisome proliferator-activated receptor delta suppresses cathepsin B expression in human endothelial cells in a posttranslational manner.
    Reichenbach G; Starzinski-Powitz A; Doll M; Hrgovic I; Valesky EM; Kippenberger S; Bernd A; Kaufmann R; Meissner M
    Exp Dermatol; 2012 Oct; 21(10):751-7. PubMed ID: 23078396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The recombinant kringle domain of urokinase plasminogen activator inhibits VEGF165-induced angiogenesis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction.
    Kim BM; Lee DH; Choi HJ; Lee KH; Kang SJ; Joe YA; Hong YK; Hong SH
    IUBMB Life; 2012 Mar; 64(3):259-65. PubMed ID: 22252975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR delta agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle.
    Lim HJ; Lee S; Park JH; Lee KS; Choi HE; Chung KS; Lee HH; Park HY
    Atherosclerosis; 2009 Feb; 202(2):446-54. PubMed ID: 18585719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts.
    Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M
    Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin 1 Mediates the Actions of Peroxisome Proliferator-Activated Receptor δ on the Oxidized Low-Density Lipoprotein-Triggered Migration and Proliferation of Vascular Smooth Muscle Cells.
    Hwang JS; Ham SA; Yoo T; Lee WJ; Paek KS; Lee CH; Seo HG
    Mol Pharmacol; 2016 Nov; 90(5):522-529. PubMed ID: 27573670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
    Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
    Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-glucose-induced prostaglandin E(2) and peroxisome proliferator-activated receptor delta promote mouse embryonic stem cell proliferation.
    Kim YH; Han HJ
    Stem Cells; 2008 Mar; 26(3):745-55. PubMed ID: 18096720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway.
    Li S; Xie H; Li S; Kang YJ
    Exp Biol Med (Maywood); 2012 Jan; 237(1):77-82. PubMed ID: 22185917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cat's whiskers tea (Orthosiphon stamineus) extract inhibits growth of colon tumor in nude mice and angiogenesis in endothelial cells via suppressing VEGFR phosphorylation.
    Ahamed MB; Aisha AF; Nassar ZD; Siddiqui JM; Ismail Z; Omari SM; Parish CR; Majid AM
    Nutr Cancer; 2012; 64(1):89-99. PubMed ID: 22136553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin inhibits endothelial cell proliferation by suppressing cell cycle proteins and PRB phosphorylation: a key to its antiangiogenic action?
    Pai R; Szabo IL; Kawanaka H; Soreghan BA; Jones MK; Tarnawski AS
    Mol Cell Biol Res Commun; 2000 Aug; 4(2):111-6. PubMed ID: 11170841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
    Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally Administered Mucolytic Drug l-Carbocisteine Inhibits Angiogenesis and Tumor Growth in Mice.
    Shinya T; Yokota T; Nakayama S; Oki S; Mutoh J; Takahashi S; Sato K
    J Pharmacol Exp Ther; 2015 Sep; 354(3):269-78. PubMed ID: 26126534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.